Pramipexole dihydrochloride
CAS No. 104632-25-9
Pramipexole dihydrochloride( Mirapex | SND 19 )
Catalog No. M10227 CAS No. 104632-25-9
A partial/full agonist of dopamine receptor with Ki of 3.9/2.2/0.5/5.1 nM for D2S/D2L/D3/D4, respeectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 302 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePramipexole dihydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionA partial/full agonist of dopamine receptor with Ki of 3.9/2.2/0.5/5.1 nM for D2S/D2L/D3/D4, respeectively.
-
DescriptionA partial/full agonist of dopamine receptor with Ki of 3.9/2.2/0.5/5.1 nM for D2S/D2L/D3/D4, respeectively; also possesses low/insignificant affinity (500–10,000 nM) for the 5-HT1A, 5-HT1B, 5-HT1D, and α2-adrenergic receptors; used for treating Parkinson's disease (PD) and restless legs syndrome (RLS).Parkinson's Disease Approved.
-
In Vitro——
-
In VivoAnimal Model:Male Wistar rats weighing 250-300 g (16-18 weeks old)Dosage:0.25 mg/kg, 1 mg/kg Administration:Intraperitoneal injection, at 1 hour, 6 hours, 12 hours, 18 hours post-occlusionResult:Decreased infarction volume as compared to tMCAO (transient middle cerebral artery occlusion)-only animals.
-
SynonymsMirapex | SND 19
-
PathwayGPCR/G Protein
-
TargetDopamine Receptor
-
RecptorDopamine Receptor
-
Research AreaNeurological Disease
-
IndicationParkinson Disease
Chemical Information
-
CAS Number104632-25-9
-
Formula Weight284.249
-
Molecular FormulaC10H19Cl2N3S
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESNC(S1)=NC2=C1C[C@@H](NCCC)CC2.Cl.Cl
-
Chemical Name2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N6-propyl-, hydrochloride (1:2), (6S)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
SLV-310
SLV-310 is a potent dopamine D2 receptor antagonist and 5-HT reuptake receptor inhibitor used in the study of neurological disorders such as bipolar disorder and schizophrenia.
-
ONC206
ONC206 is an analogue of TRAIL inducer ONC201 and is a selective antagonist of the D2-like dopamine receptors (DRD2/3/4) at nanomolar concentrations. ONC206 also has broad-spectrum anti-tumor activity. ONC206 (Oncoceutics) is an imipiridone with nanomolar potency and analogue of ONC201, a selective dopamine receptor D2 (DRD2) antagonist currently being investigated in phase II clinical trials for serous endometrial cancer (SEC).??
-
Abaperidone
Abaperidone is a potent 5-HT2A receptor and dopamine D2 receptor antagonist with an IC50 of 6.2 for 5-HT2A receptors and 17 nM for dopamine D2 receptors.
Cart
sales@molnova.com